Journal article
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
Abstract
OBJECTIVE: To determine whether the use of incretin based drugs compared with sulfonylureas is associated with an increased risk of incident pancreatic cancer in people with type 2 diabetes.
DESIGN: Population based cohort.
Authors
Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC
Journal
The BMJ, Vol. 352, ,
Publisher
BMJ
DOI
10.1136/bmj.i581
ISSN
0959-8138
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedCanadaCase-Control StudiesDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsFemaleHumansHypoglycemic AgentsIncretinsMaleMiddle AgedPancreatic NeoplasmsProportional Hazards ModelsRetrospective StudiesSulfonylurea CompoundsUnited KingdomUnited StatesYoung AdultGlucagon-Like Peptide-1 Receptor Agonists